185 related articles for article (PubMed ID: 25701036)
21. Preparation and in vivo evaluation of red blood cell membrane coated porous silicon nanoparticles implanted with
Jakobsson U; Mäkilä E; Rahikkala A; Imlimthan S; Lampuoti J; Ranjan S; Heino J; Jalkanen P; Köster U; Mizohata K; Santos HA; Salonen J; Airaksinen AJ; Sarparanta M; Helariutta K
Nucl Med Biol; 2020; 84-85():102-110. PubMed ID: 32334356
[TBL] [Abstract][Full Text] [Related]
22. Optical imaging and anticancer chemotherapy through carbon dot created hollow mesoporous silica nanoparticles.
Kang MS; Singh RK; Kim TH; Kim JH; Patel KD; Kim HW
Acta Biomater; 2017 Jun; 55():466-480. PubMed ID: 28373086
[TBL] [Abstract][Full Text] [Related]
23. Multifunctional theranostic contrast agent for photoacoustics- and ultrasound-based tumor diagnosis and ultrasound-stimulated local tumor therapy.
Moon H; Kang J; Sim C; Kim J; Lee H; Chang JH; Kim H
J Control Release; 2015 Nov; 218():63-71. PubMed ID: 26432554
[TBL] [Abstract][Full Text] [Related]
24. iRGD-modified lipid-polymer hybrid nanoparticles loaded with isoliquiritigenin to enhance anti-breast cancer effect and tumor-targeting ability.
Gao F; Zhang J; Fu C; Xie X; Peng F; You J; Tang H; Wang Z; Li P; Chen J
Int J Nanomedicine; 2017; 12():4147-4162. PubMed ID: 28615942
[TBL] [Abstract][Full Text] [Related]
25.
El-Ghareb WI; Swidan MM; Ibrahim IT; Abd El-Bary A; Tadros MI; Sakr TM
Int J Pharm; 2020 Aug; 586():119514. PubMed ID: 32565281
[TBL] [Abstract][Full Text] [Related]
26. Synergistic chemotherapeutic effect of sorafenib-loaded pullulan-Dox conjugate nanoparticles against murine breast carcinoma.
Sui J; Cui Y; Cai H; Bian S; Xu Z; Zhou L; Sun Y; Liang J; Fan Y; Zhang X
Nanoscale; 2017 Feb; 9(8):2755-2767. PubMed ID: 28155940
[TBL] [Abstract][Full Text] [Related]
27. Co-delivery of sorafenib and siVEGF based on mesoporous silica nanoparticles for ASGPR mediated targeted HCC therapy.
Zheng G; Zhao R; Xu A; Shen Z; Chen X; Shao J
Eur J Pharm Sci; 2018 Jan; 111():492-502. PubMed ID: 29107835
[TBL] [Abstract][Full Text] [Related]
28. Hybrid Decorated Core@Shell Janus Nanoparticles as a Flexible Platform for Targeted Multimodal Molecular Bioimaging of Cancer.
Sánchez A; Ovejero Paredes K; Ruiz-Cabello J; Martínez-Ruíz P; Pingarrón JM; Villalonga R; Filice M
ACS Appl Mater Interfaces; 2018 Sep; 10(37):31032-31043. PubMed ID: 30141615
[TBL] [Abstract][Full Text] [Related]
29. Inorganic Nanoparticles for Cancer Therapy: A Transition from Lab to Clinic.
Bayda S; Hadla M; Palazzolo S; Riello P; Corona G; Toffoli G; Rizzolio F
Curr Med Chem; 2018; 25(34):4269-4303. PubMed ID: 29284391
[TBL] [Abstract][Full Text] [Related]
30. iRGD Peptide-Mediated Liposomal Nanoparticles with Photoacoustic/Ultrasound Dual-Modality Imaging for Precision Theranostics Against Hepatocellular Carcinoma.
Li H; Shi S; Wu M; Shen W; Ren J; Mei Z; Ran H; Wang Z; Tian Y; Gao J; Zhao H
Int J Nanomedicine; 2021; 16():6455-6475. PubMed ID: 34584411
[TBL] [Abstract][Full Text] [Related]
31. Chemotherapeutic drug-photothermal agent co-self-assembling nanoparticles for near-infrared fluorescence and photoacoustic dual-modal imaging-guided chemo-photothermal synergistic therapy.
Li Y; Liu G; Ma J; Lin J; Lin H; Su G; Chen D; Ye S; Chen X; Zhu X; Hou Z
J Control Release; 2017 Jul; 258():95-107. PubMed ID: 28501673
[TBL] [Abstract][Full Text] [Related]
32. In vitro and in vivo evaluation of anti-nucleolin-targeted magnetic PLGA nanoparticles loaded with doxorubicin as a theranostic agent for enhanced targeted cancer imaging and therapy.
Mosafer J; Abnous K; Tafaghodi M; Mokhtarzadeh A; Ramezani M
Eur J Pharm Biopharm; 2017 Apr; 113():60-74. PubMed ID: 28012991
[TBL] [Abstract][Full Text] [Related]
33. Versatile and Finely Tuned Albumin Nanoplatform based on Click Chemistry.
Park JY; Song MG; Kim WH; Kim KW; Lodhi NA; Choi JY; Kim YJ; Kim JY; Chung H; Oh C; Lee YS; Kang KW; Im HJ; Seok SH; Lee DS; Kim EE; Jeong JM
Theranostics; 2019; 9(12):3398-3409. PubMed ID: 31281486
[TBL] [Abstract][Full Text] [Related]
34. Indocyanine green-incorporating nanoparticles for cancer theranostics.
Wang H; Li X; Tse BW; Yang H; Thorling CA; Liu Y; Touraud M; Chouane JB; Liu X; Roberts MS; Liang X
Theranostics; 2018; 8(5):1227-1242. PubMed ID: 29507616
[TBL] [Abstract][Full Text] [Related]
35. Preparation of an efficient and safe polymeric-magnetic nanoparticle delivery system for sorafenib in hepatocellular carcinoma.
Tom G; Philip S; Isaac R; Praseetha PK; Jiji SG; Asha VV
Life Sci; 2018 Aug; 206():10-21. PubMed ID: 29709652
[TBL] [Abstract][Full Text] [Related]
36. Temperature responsive porous silicon nanoparticles for cancer therapy - spatiotemporal triggering through infrared and radiofrequency electromagnetic heating.
Tamarov K; Xu W; Osminkina L; Zinovyev S; Soininen P; Kudryavtsev A; Gongalsky M; Gaydarova A; Närvänen A; Timoshenko V; Lehto VP
J Control Release; 2016 Nov; 241():220-228. PubMed ID: 27686581
[TBL] [Abstract][Full Text] [Related]
37. Biomacromolecule/lipid hybrid nanoparticles for controlled delivery of sorafenib in targeting hepatocellular carcinoma therapy.
Zhang J; Wang T; Mu S; Olerile LD; Yu X; Zhang N
Nanomedicine (Lond); 2017 Apr; 12(8):911-925. PubMed ID: 28339312
[TBL] [Abstract][Full Text] [Related]
38. A multifunctional nanocomplex for enhanced cell uptake, endosomal escape and improved cancer therapeutic effect.
Almeida PV; Shahbazi MA; Correia A; Mäkilä E; Kemell M; Salonen J; Hirvonen J; Santos HA
Nanomedicine (Lond); 2017 Jun; 12(12):1401-1420. PubMed ID: 28524813
[TBL] [Abstract][Full Text] [Related]
39. Hybrid silica-coated Gd-Zn-Cu-In-S/ZnS bimodal quantum dots as an epithelial cell adhesion molecule targeted drug delivery and imaging system.
Akbarzadeh M; Babaei M; Abnous K; Taghdisi SM; Peivandi MT; Ramezani M; Alibolandi M
Int J Pharm; 2019 Oct; 570():118645. PubMed ID: 31465835
[TBL] [Abstract][Full Text] [Related]
40. Ultrasmall Hyperbranched Semiconducting Polymer Nanoparticles with Different Radioisotopes Labeling for Cancer Theranostics.
Yi X; Xu M; Zhou H; Xiong S; Qian R; Chai Z; Zhao L; Yang K
ACS Nano; 2018 Sep; 12(9):9142-9151. PubMed ID: 30180555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
